Hepatic Steatosis as a Predictive Factor of Antiviral Effect of Pegylated Interferon Therapy in Patients With Hepatitis B.

@article{Gong2015HepaticSA,
  title={Hepatic Steatosis as a Predictive Factor of Antiviral Effect of Pegylated Interferon Therapy in Patients With Hepatitis B.},
  author={Ling Gong and Jia Liu and Jie Wang and Guoqiang Lou and Junping Shi},
  journal={Transplantation proceedings},
  year={2015},
  volume={47 10},
  pages={2886-91}
}
BACKGROUND AND AIMS This study sought to evaluate the impact of hepatic steatosis, a common hepatocyte change in nonalcoholic fatty liver disease, upon response to pegylated interferon (PEG-IFN) therapy in patients with chronic hepatitis B (CHB). METHODS Eighty-nine consecutive CHB patients from the Affiliated Hospital of Hangzhou Normal University receiving 48 weeks of PEG-IFN therapy were enrolled in this study, and 56 patients were followed up for 48 weeks among subjects with completed… CONTINUE READING